
Health Check: Mayne Pharma shares tumble after suitor threatens to walk over ‘adverse events’
Failing some smooth talking, Cosette's $600 million bid for Mayne Pharma looks to be ending in tears. Pic via Getty. Cosette Pharmaceuticals’ $600 million tilt at Mayne Pharma is in peril Analysts back Monash IVF after earnings update EBR Systems …